Luteolin-3',4'-dimethoxylether-7-O-beta-D-glucoside - Compound Card

Luteolin-3',4'-dimethoxylether-7-O-beta-D-glucoside

Select a section from the left sidebar

Luteolin-3',4'-dimethoxylether-7-O-beta-D-glucoside

Structure
Zoomed Structure
  • Family: Plantae - Lamiaceae
  • Kingdom: Plantae
  • Class: Flavonoid
    • Subclass: Flavone Glycoside
Canonical Smiles OCC1OC(Oc2cc(O)c3c(c2)oc(cc3=O)c2ccc(c(c2)OC)OC)C(C(C1O)O)O
InChI InChI=1S/C23H24O11/c1-30-14-4-3-10(5-16(14)31-2)15-8-13(26)19-12(25)6-11(7-17(19)33-15)32-23-22(29)21(28)20(27)18(9-24)34-23/h3-8,18,20-25,27-29H,9H2,1-2H3
InChIKey URUMYDGZBWVMMP-UHFFFAOYSA-N
Formula C23H24O11
HBA 11
HBD 5
MW 476.43
Rotatable Bonds 6
TPSA 168.28
LogP 0.36
Number Rings 4
Number Aromatic Rings 3
Heavy Atom Count 34
Formal Charge 0
Fraction CSP3 0.35
Exact Mass 476.13
Number of Lipinski Rule Violations 1
# Species Family Kingdom NCBI Taxonomy ID
1 Acacia sieberiana Leguminosae/Fabaceae Plantae 546664
2 Stachys aegyptiaca Lamiaceae Plantae 1391947

Showing of synonyms

  • El-Desoky S.K, Hawas U.W, et al. (2007). A new flavone glucoside from Stachys aegyptiaca. Chemistry natural compounds, 2007, 43, 542–543. [View]
  • Ngaffo CMN, Tchangna RSV, et al. (2020). Botanicals from the leaves of Acacia sieberiana had better cytotoxic effects than isolated phytochemicals towards MDR cancer cells lines.. Heliyon,2020, 6(11), e05412. [View] [PubMed]
Pubchem: 162875261

No compound-protein relationship available.

Structure

SMILES: c1ccccc1-c(cc2=O)oc(c23)cc(cc3)OC4CCCCO4

Level: 2

Mol. Weight: 476.43 g/mol

Structure

SMILES: O=c1ccoc(c12)cc(cc2)OC3CCCCO3

Level: 1

Mol. Weight: 476.43 g/mol

Structure

SMILES: c1cccc(c12)oc(cc2=O)-c3ccccc3

Level: 1

Mol. Weight: 476.43 g/mol

Structure

SMILES: c1cccc(c12)occc2=O

Level: 0

Mol. Weight: 476.43 g/mol

Structure

SMILES: C1CCOCC1

Level: 0

Mol. Weight: 476.43 g/mol

Structure

SMILES: c1ccccc1

Level: 0

Mol. Weight: 476.43 g/mol

Cytotoxic

Absorption

Caco-2 (logPapp)
-6.48
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Non-Absorbed
Madin-Darby Canine Kidney
-5.16
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Substrate
Skin Permeability
-0.26

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
1.04
Plasma Protein Binding
33.01
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Non-Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
7.25
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Toxic
Avian
Safe
Bee
Toxic
Bioconcentration Factor
-0.45
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Safe
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
0.82
Liver Injury II
Toxic
hERG Blockers
Safe
Daphnia Maga
4.94
Micronucleos
Toxic
NR-AhR
Toxic
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-210.94
Rat (Acute)
2.39
Rat (Chronic Oral)
3.63
Fathead Minnow
4.53
Respiratory Disease
Safe
Skin Sensitisation
Safe
SR-ARE
Toxic
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
560.71
Hydration Free Energy
-3.37
Log(D) at pH=7.4
1.11
Log(P)
0.87
Log S
-4.32
Log(Vapor Pressure)
-10.47
Melting Point
195.21
pKa Acid
6.66
pKa Basic
4.09

No predicted protein targets found for this compound.

Download SDF